Your experience with Jack Howarth mirrors my own.
He will be glad to tell you what he legally can; and to
shareholder's benefit he is mindful of competitive needs
for confidentiality and contractually limitations on what
he can disclose.
I have posted before than the new people on board - such
as Leroux Jooste are certainly required to sign confidentiality
agreements with the company and be bound by the insider
trading rules - but it is a sure thing that they are given all
of the insider information regarding the company - and they
have the experience and ability to interpret what it means
and pretty accurately be able to predict the company's chances
for success -
AND they choose to align themselves with ANTARES..
This and the analyst's opinions and institutional ownership -
Plus all of the available public disclosures made by Antares makes
me supremely confident that we will make a very large profit by
owning - adding to positions when one can - and holding for the
long term (maybe taking a bit off the table when we get to pretty
close to double this current price - I plan to sell about 10% of
my holdings in the $8 range to free up some cash and hold the
balance for what I believe will be an eventual acquisition of ATRS
by TEVA (or anyone of several other large Pharma companies)
on a tax free exchange of their stock for ours on a tax free basis.
by the way:
When I posted:
"I have posted before than the new people on board - such
as Leroux Jooste"
I certainly did not mean on the message board. I am quite
sure they have far more to do than visit message boards and
are too professional and competent to waste their time here.
Plus in several public company's management people are
precluded from posting on any message board by their